Translational stem cell therapy for amyotrophic lateral sclerosis

Effective treatments are urgently needed for amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease characterized by the loss of motor neurons. In 2009, the FDA approved the first phase I safety trial of direct intraspinal transplantation of neural stem cells into patients with ALS, which is currently in progress. Stem cell technologies represent a promising approach for treating ALS, but several issues must be addressed when translating promising experimental ALS therapies to patients. This article highlights the key research that supports the use of stem cells as a therapy for ALS, and discusses the rationale behind and approach to the phase I trial. Completion of the trial could pave the way for continued advances in stem cell therapy for ALS and other neurodegenerative diseases.

[1]  C. Svendsen,et al.  Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  E. Feldman,et al.  Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression , 2009, Gene Therapy.

[3]  J. Guest,et al.  Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations , 2011, Brain Research Bulletin.

[4]  D. Cleveland,et al.  Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.

[5]  J. Rothstein,et al.  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis , 2009, Annals of neurology.

[6]  W. Bamlet,et al.  Subcutaneous IGF-1 is not beneficial in 2-year ALS trial , 2008, Neurology.

[7]  Frédéric Bretzner,et al.  Target populations for first-in-human embryonic stem cell research in spinal cord injury. , 2011, Cell stem cell.

[8]  I. Fischer,et al.  Promoting directional axon growth from neural progenitors grafted into the injured spinal cord , 2009, Journal of neuroscience research.

[9]  J. Rothstein,et al.  Focal Transplantation-based Astrocyte Replacement is Neuroprotective in a Model of Motor Neuron Disease , 2008, Nature Neuroscience.

[10]  V. Koliatsos,et al.  Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord , 2007, PLoS medicine.

[11]  E. Feldman,et al.  Optimization of Immunosuppressive Therapy for Spinal Grafting of Human Spinal Stem Cells in a Rat Model of ALS , 2011, Cell transplantation.

[12]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[13]  V. Koliatsos,et al.  Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: Differentiation and structural integration into the segmental motor circuitry , 2009, The Journal of comparative neurology.

[14]  Y. Li,et al.  Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. , 2007, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.

[15]  M. Fehlings,et al.  A systematic review of cellular transplantation therapies for spinal cord injury. , 2011, Journal of neurotrauma.

[16]  J. Glass,et al.  Axonal Degeneration in Motor Neuron Disease , 2007, Neurodegenerative Diseases.

[17]  M. Scadeng,et al.  Analysis of Dosing Regimen and Reproducibility of Intraspinal Grafting of Human Spinal Stem Cells in Immunosuppressed Minipigs , 2010, Cell transplantation.

[18]  V. Koliatsos,et al.  Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats , 2011, Neuroscience Letters.

[19]  E. Feldman,et al.  Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery , 2009, Growth factors.

[20]  A. Schuyler,et al.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[21]  C. Svendsen,et al.  GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS , 2007, PloS one.

[22]  Hyoung-Tae Kim,et al.  Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice , 2009, Experimental & Molecular Medicine.

[23]  V. Koliatsos,et al.  Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats , 2006, Transplantation.

[24]  Jonathan P. Riley,et al.  Platform and Cannula Design Improvements for Spinal Cord Therapeutics Delivery , 2011, Neurosurgery.

[25]  P. Lavand'homme,et al.  Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis , 2009, Journal of neuroscience research.

[26]  J. Glass,et al.  Stem cell technology for the study and treatment of motor neuron diseases. , 2011, Regenerative medicine.

[27]  H. Deda,et al.  Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. , 2009, Cytotherapy.

[28]  E. Feldman,et al.  Cervical Multilevel Intraspinal Stem Cell Therapy: Assessment of Surgical Risks in Gottingen Minipigs , 2011, Spine.

[29]  Robert H Miller.  The promise of stem cells for neural repair , 2006, Brain Research.

[30]  Robert G. Miller,et al.  Clinical characteristics and management of ALS. , 2001, Seminars in neurology.

[31]  V. Koliatsos,et al.  Combined Immunosuppressive Agents or CD4 Antibodies Prolong Survival of Human Neural Stem Cell Grafts and Improve Disease Outcomes in Amyotrophic Lateral Sclerosis Transgenic Mice , 2006, Stem cells.

[32]  N. Ticozzi,et al.  Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? , 2010, CNS & neurological disorders drug targets.

[33]  M. Gunetti,et al.  Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial , 2010, Experimental Neurology.